Joshua A. Kazam - Jun 15, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 04:58 PM
Previous filing
Mar 9, 2022
Next filing
Jun 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +44.2K +17.06% $0.00 303K Jun 15, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.